LWLouise M. Winn

Louise M. Winn

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Louise M. Winn has a total of 59 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The maternal–placental–fetal liver axis: A mechanistic framework for understanding benzene developmental hematotoxicity

    by Perri M. Grant, Megan E. Cull, Holly Mackay, Caitlyn I. Kirkpatrick, Louise M. Winn

  • Open Access

    Mind the Litter: The Critical Role of Intralitter Variables in Reproductive and Developmental Toxicology Research

    by Lauren T. L. Brown, Megan E. Cull, Delaine Pereira, Perri M. Grant, Louise M. Winn

    Background: Animal models remain essential for understanding developmental toxicology, providing insights into how in utero exposures affect fetal and placental outcomes. Litter‐bearing species are widely used due to their efficiency and reproducibility, but conventional approaches often summarize outcomes at the litter level, masking meaningful within‐litter variability. Aim: This review highlights three primary sources of intralitter variability: litter size, uterine implantation location, and fetal sex, and their influence on fetal and placental growth, mortality, and malformations. Discussion: Larger litters restrict fetal growth through intrauterine competition, while toxicant‐induced changes in litter size can obscure or exaggerate effects. Implantation location within uterine horns influences perfusion, nutrient delivery, and local exposure to hormones or toxicants, introducing spatially dependent vulnerability. Fetal sex further modifies responses, as male and female fetuses and placentas differ in growth trajectories, gene expression, and adaptive capacity, leading to sex‐specific susceptibility to toxicants. Conclusion: Ignoring these sources of variability risks overlooking subtle effects and vulnerable subpopulations, misinterpreting outcomes, and reducing the translational value of animal studies. We argue that incorporating intralitter variables into experimental design and statistical analyses enhances the accuracy, reproducibility, and interpretability of developmental toxicology research. By refining the use of animal models in line with the 3Rs framework, researchers can maximize the information gained per pregnancy and improve risk assessment for human maternal‐fetal health.

  • Open Access

    Benzene-induced growth restriction and compensatory rebound in mouse fetuses and placentas

    by Megan E. Cull, Lauren T.L. Brown, Perri M. Grant, Lihua Xue, Louise M. Winn


  • Open Access

    Triphenyl phosphate induces coordinated DNA methylation and gene expression changes in aquatic embryonic cells

    by Logan S Germain, Benjamin P Ott, Charles C T Hindmarch, Louise M Winn

    Triphenyl phosphate (TPHP) is a high-production-volume flame retardant and plasticizer that is widely detected in the environment and in biomonitoring studies. TPHP exposure has been linked to endocrine disruption, metabolic disruption, genotoxicity, and neurodevelopmental effects in vitro and in vivo. The diverse toxicological outcomes across studies suggest disruption of fundamental regulatory processes, such as epigenetic control of gene expression. Here, we used an immortalized embryonic cell line derived from steelhead trout (STE-137) to investigate coordinated transcriptional and epigenetic responses to TPHP exposure. Cells were exposed to 0 or 80 μM TPHP for 24 h, followed by RNA sequencing (RNA-seq) or whole-genome bisulfite sequencing (WGBS). Differential expression analysis identified 1622 significant genes, with significant enrichment of DNA replication and repair, cell cycle regulation, and endocrine signaling pathways and prominent lipid metabolism genes. Weighted gene co-expression network analysis revealed modules highly correlated with exposure, including those enriched for protein and amino acid metabolism, ion transport, and genomic stability. WGBS methylome analysis detected 382 differentially methylated regions (DMRs), the majority hypermethylated and within gene bodies. Notable alterations included a DMR in the htr2cl1 gene, encoding a serotonin receptor, and the brca2 gene, a key DNA damage enzyme. Integration of RNA-seq and WGBS datasets identified nine genes with both expression and methylation changes, alongside altered gene expression of several key epigenetic regulators. Our results provide molecular evidence for early initiating events relevant to adverse outcome pathways and highlight the importance of epigenetic endpoints in developmental toxicity assessment.


  • Open Access

    Acetaminophen Use During Pregnancy and Neurodevelopmental Risk: Biological Plausibility

    by Delaine Pereira, Anick Bérard, Justine Pleau, Lisiane F. Leal, Louise M. Winn


  • Open Access

    First assessment of the ecotoxicological effects of the tire antioxidant 6PPD on early life stages of the popular sport fish species, the largemouth bass ( Micropterus nigricans )

    by Katryna J Seabrook, Louise M Winn, Markus Brinkmann, Julie E Adams, Ashley Canete, Linna Xie, Hui Peng, Stacey A Robinson, Diane M Orihel

    N-(1,3-dimethylbutyl)-N'-phenyl-p-phenylenediamine (6PPD) is a widely used rubber antioxidant, entering aquatic ecosystems through roadway runoff of tire wear particles. A transformation product of 6PPD, 6PPD-quinone, has been detected in watersheds at concentrations acutely toxic to some salmonid fish species. We evaluated the toxicity of 6PPD to early-life stage largemouth bass (Micropterus nigricans) in a series of outdoor aquatic microcosm experiments. Wild-collected embryos were chronically exposed to 6PPD and its potential transformation products in natural lake water under ambient environmental conditions. In a preliminary 96-h experiment, 6PPD was toxic to largemouth bass embryos with a 96-h LC50 of 42.8 µg/L. Interestingly, we found that exposure to 6PPD-quinone did not cause mortality in largemouth bass embryos beyond concentrations of maximum solubility in water. To further investigate the developmental toxicity of 6PPD, largemouth bass were exposed to 6PPD (modelled time-weighted average concentrations ranging from 0.1–3.7 µg/L) for 10 d, which spanned the embryonic to yolk-sac larval life stages. Exposure to 6PPD decreased yolk sac absorption as well as increased the occurrence and severity of malformations compared to the solvent control. As the first toxicological assessment of 6PPD with largemouth bass, our findings provide an important first step in understanding how 6PPD affects the development of the early life stages under environmentally realistic conditions.


  • Open Access

    Intralitter Variability Influences the Developmental Impact of Valproic Acid Exposure in CD‐1 Mice

    by Lauren T. L. Brown, Megan E. Cull, Lihua Xue, Louise M. Winn

    Valproic acid (VPA) is an antiepileptic and mood‐stabilizing drug that causes teratogenic effects, including neural tube defects (NTDs), when taken during pregnancy. Although animal models are widely used to study VPA teratogenicity, most rely on litter means, which overlook variability within the litter. In litter‐bearing species like mice, fetal development can vary by sex, uterine horn location, and intrauterine position. This study examined whether these intralitter variables affect fetal and placental outcomes following VPA exposure. Pregnant CD‐1 mice received a subcutaneous injection of saline (vehicle control), 400 mg/kg, or 600 mg/kg VPA on gestational day (GD) 9 and were euthanized on GD 18. Fetuses and placentas were collected, weighed, and stratified by exposure, NTD status, sex, uterine horn location, and intrauterine position. Fetal and placental weights were normalized to maternal weight gain and live litter size or the number of live fetuses in each uterine horn. VPA exposure produced a clear dose‐dependent effect, with 600 mg/kg significantly increasing postimplantation losses and NTD frequency. These effects were further influenced by intralitter variables, particularly sex and uterine horn location. Fetal weight increased at 400 mg/kg VPA but was unchanged at 600 mg/kg, while placental weight decreased and placental efficiency increased at both doses, suggesting possible compensatory adaptations. At 600 mg/kg VPA, sex differences in placental weight and efficiency were lost, and fetuses in the left uterine horn were significantly lighter than those in the right, indicating location‐dependent susceptibility. Intrauterine position did not significantly affect outcomes. These findings demonstrate that intralitter variables influence fetal and placental responses to VPA and underscore the need to account for these factors to improve the translational relevance of developmental toxicology studies.


  • Open Access

    A Narrative Review on the Effect of Valproic Acid on the Placenta

    by Lauren T. L. Brown, Delaine Pereira, Louise M. Winn

    Background: Valproic acid (VPA) is an antiepileptic and mood‐stabilizing drug with well‐established teratogenic risks when taken during pregnancy. While its harmful effects on fetal development are well known, less attention has been given to its impact on placental development and function, despite the placenta's critical role in pregnancy.Aim: This narrative review examines how VPA exposure affects placental growth, morphology, nutrient transport, and epigenetic modifications. It also considers whether placental dysfunction may contribute VPA's teratogenic effects.Results: Evidence suggests that VPA disrupts placental structure and growth, alters the expression of nutrient transporters, such as those for folate, glucose, and amino acids, and modifies the placental epigenome, including globally decreased DNA methylation and increased histone acetylation.Discussion: It is hypothesized that these epigenetic changes may influence chromatin remodelling and trophoblast gene expression, though this connection has not been fully established. Such epigenetic dysregulation may result in aberrant gene expression that underlies the structural and functional impairments observed in the placenta, potentially compromising its ability to support fetal development and contributing to VPA's teratogenic effects. Findings across studies, however, are inconsistent, varying with dose, timing of exposure, and model system. Furthermore, there is a lack of research examining sex‐specific differences in placental responses to VPA, despite evidence that male and female placentas exhibit distinct growth patterns, gene expression profiles, and susceptibilities to environmental insults.Conclusion: Addressing these knowledge gaps through targeted research will improve our understanding of how VPA affects the placenta and its role in teratogenesis.